Search A-Z index Contact
University of Cambridge Home Professor Chris Smith
University of Cambridge >  School of the Biological Sciences  >  Department of Biochemistry spacerStaff email list spacerPhone
 
Research Groups
 
Service & Research Support
Facilities
 
Past members
last known active weblink
 

 

 

 

Prof. Chris Smith

Regulation of Alternative Pre-mRNA Splicing

Research Groupings: Structural and molecular cell biology | Functional genomics, systems biology and genetic medicine

Our research focuses upon understanding the molecular basis of alternative pre-mRNA splicing. This is a process whereby individual genes are able to produce multiple mRNAs, often in a strictly cell-type or developmentally-regulated manner. It is a major form of gene regulation which helps to bridge the gap between the relatively limited number of genes in metazoan genomes and the far greater complexity of their proteomes. Indeed recent estimates indicate that the majority of human genes are alternatively spliced. Autoregulation of PTB expression imageOur group has used two major model systems to characterize the molecular mechanisms that regulate alternative splicing. The a-tropomyosin and a-actinin genes contain pairs of mutally exclusive exons, one of which is used widely in many cell types while the other is only selected in differential smooth muscle cells. A reversal of this splicing pattern accompanies the phenotype alterations of vascular smooth muscle cells that occur in atherosclerosis. The overall goal of the research is to characterize the factors that cause the switch of splicing pattern in smooth muscle cells and to understand their mode of action.

One of the splicing regulatory proteins in which we are interested, PTB, itself illustrates an important way in which alternative splicing can regulate gene expression without producing additional protein isoforms. This involves the production of RNAs that are substrates for the process of Nonsense Mediated Decay (NMD) rather than for translation. In the case of PTB an autoregulatory circuit involving alternative splicing directed NMD prevents accumulation of excessive amounts of PTB. We are currently engaged in investigating the prevalence and importance alternative splicing leading to NMD.

Lab members
Miguel Coelho, Christopher Edge, Clare Gooding, Martina Hallegger, Miriam Llorian, Jenny Reed, Lit Yeen Tan

References

  1. M.C.Wollerton, C. Gooding, E.J. Wagner, M.A. Garcia-Blanco and C.W.J. Smith. Autoregulation of polypyrimidine tract binding protein by alternative splicing leading to nonsense mediated decay. Mol. Cell 13, 91-100 (2004).
  2. A.J. Matlin, F. Clark and C.W.J. Smith. Understanding alternative splicing; towards a cellular code.  Nature Reviews Mol. Cell. Biol. 6, 386-398 (2005).
  3. A.P. Rideau, C. Gooding, P.J. Simpson, T.P. Monie, M. Lorenz, S. Hüttelmaier, R.H. Singer, S. Matthews, S. Curry & C.W.J. Smith. A peptide motif in Raver1 mediates splicing repression by interaction with the PTB RRM2 domain. Nature Structural and Molecular Biology. 13, 839-848 (2006).
  4. R.H. Spellman, M. Llorian and C.W.J. Smith. Functional redundancy and cross-regulation between the splicing regulator PTB and its paralogs nPTB and ROD1. Mol. Cell. 27, 420-434, (2007)
  5. M. Llorian, S. Schwartz, T. Clark, D. Hollander, L-Y Tan, R. Spellman, A. Gordon, A.C. Schweitzer, P. de la Grange, G. Ast, & C.W.J. Smith. Position-dependent alternative splicing activity revealed by global profiling of alternative splicing events regulated by PTB. Nature Structural & Molecular Biology 17, 1114-1123, (2010)

Valid XHTML 1.0!